chr20-259232-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_207469.3(DEFB132):c.214G>A(p.Gly72Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000244 in 1,612,808 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_207469.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152038Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000103 AC: 26AN: 251468Hom.: 0 AF XY: 0.0000957 AC XY: 13AN XY: 135910
GnomAD4 exome AF: 0.000253 AC: 369AN: 1460652Hom.: 0 Cov.: 34 AF XY: 0.000233 AC XY: 169AN XY: 726670
GnomAD4 genome AF: 0.000158 AC: 24AN: 152156Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74392
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 20, 2023 | The c.214G>A (p.G72S) alteration is located in exon 2 (coding exon 2) of the DEFB132 gene. This alteration results from a G to A substitution at nucleotide position 214, causing the glycine (G) at amino acid position 72 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at